Breaking News
0

ContraFect Corp (CFRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ContraFect Corp's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.320 -0.015    -4.40%
16/10 - Closed. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US2123261024 
CUSIP: 212326102
  • Volume: 93,652
  • Bid/Ask: 0.310 / 0.347
  • Day's Range: 0.310 - 0.350
ContraFect Corp 0.320 -0.015 -4.40%

CFRX Overview

 
This is the main ContraFect Corp stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.334
Day's Range0.31 - 0.35
RevenueN/A
Open0.35
52 wk Range0.269 - 2.629
EPS0.05
Volume93,652
Market Cap25.39M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)264,470
P/E Ratio5.82
Beta0.19
1-Year Change - 84.47%
Shares Outstanding79,409,556
Next Earnings DateNov 07, 2019
What is your sentiment on ContraFect Corp?
or
Market is currently closed. Voting is open during market hours.

ContraFect Corp News


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Falling Three Methods 1H Current
Completed Patterns
Bullish doji Star 1M 1 Sep 19
Engulfing Bearish 1W 3 Sep 22, 2019
Upside Gap Three Methods 1W 3 Sep 22, 2019

ContraFect Corp Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 0.320 0.310 0.347 93,652 -4.40% USD 16/10  
  Stuttgart 0.274 0.368 0.429 0 0.00% EUR 16/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Netflix 286.28 288.17 280.74 +2.03 +0.71% 18.41M 16/10  
  Apple 234.37 235.24 233.20 -0.95 -0.40% 19.29M 16/10  
  Facebook 189.55 189.70 186.90 +0.66 +0.35% 10.56M 16/10  
  Alphabet A 1,243.00 1,254.19 1,238.53 +0.76 +0.06% 1.15M 16/10  
  Amazon.com 1,777.43 1,786.24 1,770.52 +10.05 +0.57% 2.80M 16/10  
  Can Fite Biopharma ADR 2.3200 2.4354 2.1409 +0.1532 +7.07% 89.20K 16/10  
  Tesla 259.75 262.10 256.92 +1.86 +0.72% 6.70M 16/10  
  IBM 142.11 142.95 141.39 -0.89 -0.62% 5.92M 16/10  
  Morgan Stanley 42.79 43.15 42.45 +0.26 +0.61% 10.16M 16/10  
  Bank of America 30.17 30.72 30.15 +0.44 +1.48% 87.48M 16/10  

ContraFect Corp Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

20

Equity Type

ORD

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin candidates includes CF-301, CF-302, CF-303, CF-309, CF-304, CF-305, CF-306, CF-307 and CF-308. Its other product candidate includes CF-404. Its lysin product candidate, CF-301 is developed for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-resistant Staph aureus and susceptible Staph aureus strains. Its product candidate, CF-404 is used for the treatment of human influenza, including seasonal and pandemic varieties. It focuses on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CFRX Comments

Write your thoughts about ContraFect Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
stats con chris
stats con chris Jun 07, 2019 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this Is manipulated
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email